294 related articles for article (PubMed ID: 28385126)
21. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
[TBL] [Abstract][Full Text] [Related]
22. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
Gargiulo MLÁ; Khoury M; Gómez G; Grimaudo S; Suárez L; Collado MV; Sarano J
Medicina (B Aires); 2018; 78(5):329-335. PubMed ID: 30285925
[TBL] [Abstract][Full Text] [Related]
23. Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis.
Xue J; Yang J; Yang L; Zhou S; Ji C; Wang X; Yu N; Liu X; Chi S
J Immunol Res; 2017; 2017():6861575. PubMed ID: 28373995
[TBL] [Abstract][Full Text] [Related]
24. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
25. Growing international evidence for urinary biomarker panels identifying lupus nephritis in children - verification within the South African Paediatric Lupus Cohort.
Smith EMD; Lewandowski LB; Jorgensen AL; Phuti A; Nourse P; Scott C; Beresford MW
Lupus; 2018 Dec; 27(14):2190-2199. PubMed ID: 30348048
[TBL] [Abstract][Full Text] [Related]
26. Serum thiols as a biomarker of disease activity in lupus nephritis.
Lalwani P; de Souza GK; de Lima DS; Passos LF; Boechat AL; Lima ES
PLoS One; 2015; 10(3):e0119947. PubMed ID: 25799079
[TBL] [Abstract][Full Text] [Related]
27. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
28. Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).
Donohue SJ; Midgley A; Davies JC; Wright RD; Bruce I; Beresford MW; Hedrich CM; ;
Clin Immunol; 2020 May; 214():108375. PubMed ID: 32135275
[TBL] [Abstract][Full Text] [Related]
29. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
[TBL] [Abstract][Full Text] [Related]
31. Cross-sectional study of plasma Axl, ferritin, IGFBP4 and sTNFR2 as biomarkers of disease activity in childhood-onset SLE: A study of the Pediatric Nephrology Research Consortium.
Soliman SA; Haque A; Mason S; Greenbaum LA; Hicks MJ; Mohan C; Wenderfer SE
Lupus; 2021 Aug; 30(9):1394-1404. PubMed ID: 33990158
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis.
Soliman WM; Sherif NM; Ghanima IM; El-Badawy MA
Reumatol Clin (Engl Ed); 2020; 16(4):255-261. PubMed ID: 30166230
[TBL] [Abstract][Full Text] [Related]
33. Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus.
Lerkvaleekul B; Apiwattanakul N; Tangnararatchakit K; Jirapattananon N; Srisala S; Vilaiyuk S
PLoS One; 2022; 17(2):e0263536. PubMed ID: 35130317
[TBL] [Abstract][Full Text] [Related]
34. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
35. [Expression and diagnostic value of plasma miR-145 and miR-183 in children with lupus nephritis].
Lin LJ; Mai LJ; Chen G; Zhao EN; Xue M; Su XD
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):632-637. PubMed ID: 32571464
[TBL] [Abstract][Full Text] [Related]
36. Peripheral neutrophil CD64 index combined with complement, CRP, WBC count and B cells improves the ability of diagnosing bacterial infection in SLE.
Feng M; Zhang SL; Liang ZJ; Wang YL; Zhao XC; Gao C; Guo H; Luo J
Lupus; 2019 Mar; 28(3):304-316. PubMed ID: 30712491
[TBL] [Abstract][Full Text] [Related]
37. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
38. Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
Davies JC; Midgley A; Carlsson E; Donohue S; Bruce IN; Beresford MW; Hedrich CM
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32723832
[TBL] [Abstract][Full Text] [Related]
39. Urine S100 proteins as potential biomarkers of lupus nephritis activity.
Turnier JL; Fall N; Thornton S; Witte D; Bennett MR; Appenzeller S; Klein-Gitelman MS; Grom AA; Brunner HI
Arthritis Res Ther; 2017 Oct; 19(1):242. PubMed ID: 29065913
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus.
Keusseyan SP; da Silva NP; Hilário MO; Okuda EM; Terreri MT; Andrade LE
Rev Bras Reumatol; 2012 Oct; 52(5):695-712. PubMed ID: 23090370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
